Timothy Archer - May 10, 2021 Form 4 Insider Report for LAM RESEARCH CORP (LRCX)

Role
President and CEO
Signature
Leign Cramer by Power of Attorney
Stock symbol
LRCX
Transactions as of
May 10, 2021
Transactions value $
-$2,774,596
Form type
4
Date filed
5/11/2021, 02:41 PM
Previous filing
May 10, 2021
Next filing
Jun 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LRCX Common Stock Options Exercise $217K +1.49K +1.64% $145.73* 92.3K May 10, 2021 Direct F1, F2
transaction LRCX Common Stock Sale -$925K -1.49K -1.61% $621.41 90.8K May 10, 2021 Direct F1, F2
transaction LRCX Common Stock Options Exercise $217K +1.49K +1.64% $145.73* 92.3K May 10, 2021 Direct F1, F2
transaction LRCX Common Stock Sale -$925K -1.49K -1.61% $621.41 90.8K May 10, 2021 Direct F1, F2
transaction LRCX Common Stock Options Exercise $217K +1.49K +1.64% $145.73* 92.3K May 10, 2021 Direct F1, F2
transaction LRCX Common Stock Sale -$925K -1.49K -1.61% $621.41 90.8K May 10, 2021 Direct F1, F2
holding LRCX Common Stock 4.72K May 10, 2021 By 401(k)
holding LRCX Common Stock 557 May 10, 2021 By Spouse 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LRCX Employee Stock Option (Right to Buy) Options Exercise -$217K -1.49K -4.54% $145.73* 31.3K May 10, 2021 Common Stock 1.49K $145.73 Direct F3
transaction LRCX Employee Stock Option (Right to Buy) Options Exercise -$217K -1.49K -4.76% $145.73* 29.8K May 10, 2021 Common Stock 1.49K $145.73 Direct F3
transaction LRCX Employee Stock Option (Right to Buy) Options Exercise -$217K -1.49K -5% $145.73* 28.3K May 10, 2021 Common Stock 1.49K $145.73 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19,2020.
F2 The amount reported includes shares subject to unvested restricted stock units.
F3 The stock options will become exercisable over four years, a quarter on the one-year anniversary of the grant date and the remainder on a pro-rated basis on the 6th day of every month thereafter for the next 36 months.